Beta Bionics, Inc. Earnings Per Share (Diluted)
Beta Bionics, Inc. (BBNX) reported Earnings Per Share (Diluted) of -$0.53 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-29
- Beta Bionics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.53.
- Beta Bionics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.49.
- Beta Bionics, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.30.
- Beta Bionics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.33.
- Beta Bionics, Inc. earnings per share, diluted for fiscal 2025 was -$1.81.
- Beta Bionics, Inc. earnings per share, diluted for fiscal 2024 was -$8.60.
- Beta Bionics, Inc. earnings per share, diluted for fiscal 2023 was -$8.31.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.53 10-Q · filed 2026-07-29 | -$1.02 10-Q · filed 2026-07-29 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$1.65 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2026-03-31 | -$0.49 10-Q · filed 2026-04-21 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-04-21 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-04-21 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$1.81 10-K · filed 2026-02-24 |
| 2025-09-30 | -$0.33 10-Q · filed 2025-10-28 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$1.52 10-Q · filed 2025-10-28 | -$2.50 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-06-30 | -$0.39 10-Q · filed 2026-07-29 | -$1.23 10-Q · filed 2026-07-29 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$3.36 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-03-31 | -$0.93 10-Q · filed 2026-04-21 | -$2.50 derived: net income ÷ weighted average shares · filed 2026-04-21 | -$3.85 derived: net income ÷ weighted average shares · filed 2026-04-21 | -$5.66 derived: net income ÷ weighted average shares · filed 2026-04-21 |
| 2024-12-31 | -$2.72 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$4.18 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$6.53 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$8.60 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.46 10-Q · filed 2025-10-28 | -$3.79 derived: net income ÷ weighted average shares · filed 2025-10-28 | -$5.86 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$2.37 10-Q · filed 2025-07-29 | -$4.44 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | -$2.07 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$8.31 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |